Anuh Pharma's profit slipped 13% despite 16.6% revenue growth
Revenue rose to ₹771.66 cr but PAT fell to ₹41.05 cr; board recommends ₹1.50/sh dividend.
— 3 earlier stories on Anuh Pharma Ltd. →Mkt cap₹785 cr
P/E19.14×
ROE14.52%
Debt / eq.0.03
Div yld1.91%
13.3% Decline in profit after tax to ₹41.05 cr
What's new
- Annual profit fell 13.3% to ₹41.05 cr despite 16.6% revenue growth to ₹771.66 cr.
- Board recommends ₹1.50 per share dividend for FY26.
- Audited results for quarter and year ended March 31, 2026 approved.
Why this matters
The gap between double-digit revenue growth and a profit decline points to margin compression. The next test is whether this is a one-off quarter or the start of a trend.
What we're watching
- Whether FY27 guidance or commentary addresses margin recovery.
- Any specific cost head that caused the dip — raw materials or SG&A.
- Q4 alone numbers if disclosed separately.
The full read
Anuh Pharma's FY26 audited results show revenue climbing 16.6% to ₹771.66 crore, while profit after tax dropped 13.3% to ₹41.05 crore. That divergence — growth without earnings follow-through — is the story. The board recommended a ₹1.50 per share dividend, a routine payout. The filing is a scheduled outcome, but the financial pattern is not: top-line momentum meeting bottom-line headwinds. What matters now is whether margins stabilise or erode further.
Mentioned: ₹771.66 cr revenue · ₹41.05 cr PAT · ₹1.50/sh dividend
Company snapshot
Anuh Pharma Ltd.
Pharmaceuticals
₹763 cr
P/E 18.58×
Latest quarter · Mar 2026
Sales₹202 cr
Net profit₹12 cr
Op. margin+9.8%
EPS₹1.17
Strength & growth
Debt / equity0.03×
Current ratio2.11×
Sales CAGR+8.9%
EPS CAGR−0.2%
Story so far
All notes on ANUHPHR →- 20 May 2026 · 9:58 PM IST Anuh Pharma's profit slipped 13% despite 16.6% revenue growth
- 62d ago Anuh Pharma's FY26 revenue rose 16.6% but profit fell 13.3%
- 63d ago Anuh Pharma revenue up 16%, but profit slips 13% in FY26
- 63d ago Anuh Pharma's profit slipped 13% even as revenue rose 17% in FY26